Damora Therapeutics, Inc. (DMRA) — Stock Score Summary

Damora Therapeutics, Inc. (DMRA) has a MoatMap StockRank of 37/100 based on Quality (30/100), Value (38/100), and Momentum (55/100) factor scores. The current signal is HOLD.

Damora Therapeutics, Inc. is a biotechnology company dedicated to the discovery and development of novel therapeutic candidates for treating various diseases. Its competitive strength derives from its proprietary scientific platforms, intellectual property portfolio, and specialized research capabilities. As a clinical-stage biotech firm, its value is significantly tied to the progress and successful outcomes of its drug pipeline through clinical trials and regulatory approvals.

Key Financial Metrics

Price$25.30
Market Cap$1.6B
P/E (Forward)-11.42
Price/Book3.82
Return on Equity-89.5%
Return on Invested Capital-87.7%
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-17M

Damora Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Damora Therapeutics, Inc.’s (DMRA) StockRank?
MoatMap’s StockRank for Damora Therapeutics, Inc. (DMRA) is 37/100, with a Hold signal. It is a composite of Quality (30), Value (38), and Momentum (55) factor ranks across MoatMap’s 19,000+ stock universe.
Does Damora Therapeutics, Inc. have an economic moat?
Damora Therapeutics, Inc. (DMRA) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Damora Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Damora Therapeutics, Inc. (DMRA) is Hold, based on a StockRank of 37/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Damora Therapeutics, Inc. in?
Damora Therapeutics, Inc. (DMRA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksDMRA deep dive reportAI ChampionsHow we score stocksSense-check another stock